Public Consultation on Podiatry Prescribing in Tasmania

NewsBot · Sep 18, 2015

Members do not see these Ads. Sign Up.
Public Consultation on Podiatry Prescribing in Tasmania

Public comment is being sought on proposed changes to the Poisons Act 1971 which would enable podiatrists and podiatric surgeons to prescribe a limited range of Schedule 2, 3, 4 and 8 medicines in Tasmania.

The Podiatry Board of Australia (PodBA) has established a governance structure to support podiatry prescribing which underpins the podiatry prescribing frameworks currently in place in all jurisdictions, except Tasmania. Podiatry prescribing has been successfully and safely implemented in these other jurisdictions and there is growing evidence demonstrating the benefits of podiatry prescribing. One of the potential benefits for Tasmania is the opportunity to foster 'shared care' models of care between endorsed podiatrists and medical professionals, which will foster inter-professional collaboration providing more timely access to scheduled medicines and improved treatment outcomes.

Currently in Tasmania, legislation limits podiatry prescribing to a select list of Schedule 4 local anaesthetics, thus limiting the capacity of Tasmanian endorsed podiatrists to work to their full scope of practice. The Department of Health and Human Services has released a framework for the implementation of prescribing by endorsed podiatrists in Tasmania and is available for interested stakeholders as a Consultation Paper.

The proposed Framework for the implementation of prescribing by endorsed podiatrists in Tasmania, as outlined in the Consultation Paper, is based on the PodBA governance arrangements for endorsement for scheduled medicines and the Health Professionals Prescribing Pathway (HPPP), as endorsed by the Standing Council on Health in November 2013. The Framework outlines options for consideration in determining the list of scheduled medicines available to podiatrists endorsed by the PodBA.

The preferred option is for Tasmania to adopt the full list of scheduled medicines approved by the PodBA. This approach has been adopted in Western Australia, New South Wales and Victoria.

You are invited to provide written submissions regarding implementation of the Prescribing Framework as outlined in the Consultation paper.
Click to expand...

NewsBot The Admin that posts the news.

Inaccuracies in the public advertising about calcaneal apophysitis

Scholarly Publication by Content Experts Presenting at National Society Foot Meetings

8-week locum in WA Public Health Feb 2022

Hobart- Public Sector Part time Community Podiatrist & Senior Inpatient Podiatrist position

WA Public Hospital Leave Cover Feb 2022

Discrepeances in foot related clinical trials between registration and publications

myFootDr initial public offering

Share This Page